Jianping’s first-author paper discussing the therapeutic targeting and validation of tyrosine phosphatase non-receptor type 22 (PTPN22 / LYP) was published in the Journal of Clinical Investigation (IF = 14.808). Check it out here. Congratulations Jianping et al.!
